Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells

Glioma stem cells (GSCs) contribute to tumor recurrence and drug resistance. This study characterizes the tumorigenesis of CD133+ cells and their sensitivity to pharmacological inhibition.